Polishing the tarnished silver bullet: the quest for new antibiotics
Author(s) -
Mark A. T. Blaskovich,
Mark S. Butler,
Matthew A. Cooper
Publication year - 2017
Publication title -
essays in biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.351
H-Index - 66
eISSN - 1744-1358
pISSN - 0071-1365
DOI - 10.1042/ebc20160077
Subject(s) - silver bullet , antibiotics , business , stewardship (theology) , intensive care medicine , risk analysis (engineering) , antibiotic stewardship , drug , microbiology and biotechnology , biochemical engineering , medicine , biology , engineering , pharmacology , political science , antibiotic resistance , law , politics , sociology , anthropology
We are facing a potential catastrophe of untreatable bacterial infections, driven by the inexorable rise of extensively drug-resistant bacteria, coupled with a market failure of pharmaceutical and biotech companies to deliver new therapeutic options. While global recognition of the problem is finally apparent, solutions are still a long way from being implemented. In addition to drug stewardship programmes and better diagnostics, new antibiotics are desperately needed. The question remains as to how to achieve this goal. This review will examine the different strategies being applied to discover new antibiotics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom